SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-21-000533
Filing Date
2021-02-12
Accepted
2021-02-12 16:05:04
Documents
46
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K cns_10k-123120.htm 10-K 642331
2 CERTIFICATION cns_10k-ex3101.htm EX-31.1 9761
3 CERTIFICATION cns_10k-ex3102.htm EX-31.2 9613
4 CERTIFICATION OF OFFICER cns_10k-ex3201.htm EX-32.1 3532
5 CERTIFICATION OF OFFICER cns_10k-ex3202.htm EX-32.2 3551
  Complete submission text file 0001683168-21-000533.txt   2832905

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cnsp-20201231.xml EX-101.INS 382317
7 XBRL SCHEMA FILE cnsp-20201231.xsd EX-101.SCH 31089
8 XBRL CALCULATION FILE cnsp-20201231_cal.xml EX-101.CAL 34005
9 XBRL DEFINITION FILE cnsp-20201231_def.xml EX-101.DEF 133447
10 XBRL LABEL FILE cnsp-20201231_lab.xml EX-101.LAB 254107
11 XBRL PRESENTATION FILE cnsp-20201231_pre.xml EX-101.PRE 199833
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39126 | Film No.: 21627149
SIC: 2834 Pharmaceutical Preparations